.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Covington
Daiichi Sankyo
Baxter
Queensland Health
Cipla
Chinese Patent Office
Dow
US Department of Justice
Johnson and Johnson

Generated: July 26, 2017

DrugPatentWatch Database Preview

PROLIXIN ENANTHATE Drug Profile

« Back to Dashboard

What is the patent landscape for Prolixin Enanthate, and what generic Prolixin Enanthate alternatives are available?

Prolixin Enanthate is a drug marketed by Apothecon and is included in one NDA.

The generic ingredient in PROLIXIN ENANTHATE is fluphenazine enanthate. There are eighteen drug master file entries for this compound. Additional details are available on the fluphenazine enanthate profile page.

Summary for Tradename: PROLIXIN ENANTHATE

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list13
Clinical Trials: see list20
Patent Applications: see list427
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PROLIXIN ENANTHATE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apothecon
PROLIXIN ENANTHATE
fluphenazine enanthate
INJECTABLE;INJECTION016110-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Baxter
Express Scripts
Harvard Business School
Merck
Farmers Insurance
Queensland Health
Accenture
Johnson and Johnson
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot